Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Boost for VRX-GSK Epilepsy Drug
Yahoo/Zacks.com
Tuesday, January 25, 2011 - 11:07am
tags:
epilepsy, GSK, JNJ, Pfizer, Valeant Pharmaceuticals, Europe, retigabine
Glaxo Exec Wants To Know ‘What Went Wrong?’
Pharmalot
Tuesday, January 25, 2011 - 11:06am
tags:
GSK
Eisai’s Severe Sepsis Drug Fails in Final-Stage Study
Bloomberg
Tuesday, January 25, 2011 - 11:04am
tags:
Eisai, sepsis, eritoran
BioSante rallies on FDA move for melanoma vaccine
Marketwatch
Tuesday, January 25, 2011 - 10:48am
tags:
FDA, BioSante, vaccines, melanoma
Savient Names Lilly’s John Johnson Chief Executive
Bloomberg
Tuesday, January 25, 2011 - 10:46am
tags:
Savient, Eli Lilly, John Johnson
J&J reports lower 4Q profit, revenue
Yahoo/AP
Tuesday, January 25, 2011 - 9:32am
tags:
earnings, JNJ
Roche Scores Big With Plexxikon and Immunogen Deals
Seeking Alpha
Tuesday, January 25, 2011 - 9:30am
tags:
Roche, Immunogen, Plexxikon, personalized medicine
Amgen’s Purchase of Cancer Drugmaker Biovex May Mean More Deals
Bloomberg
Tuesday, January 25, 2011 - 9:30am
tags:
Amgen, BioVex, cancer, M&A
Teva Receives FDA Action Letter For Generic Lovenox®
Yahoo
Tuesday, January 25, 2011 - 9:28am
tags:
Lovenox, generics, Teva Pharmaceuticals, FDA
Patients With Cancer Like Steve Jobs Gain Months From Novartis, Pfizer drugs
Bloomberg
Tuesday, January 25, 2011 - 9:28am
tags:
cancer, Novartis, Pfizer
Merck to fund rotavirus vaccine project
FT.com
Tuesday, January 25, 2011 - 9:26am
tags:
Merck, rotavirus, vaccines
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Bloomberg
Monday, January 24, 2011 - 8:22pm
tags:
BioVex, Amgen, M&A, Oncovex
Amgen earns $1 billion in fourth quarter
Marketwatch
Monday, January 24, 2011 - 6:28pm
tags:
earnings, Amgen
[video]Can Johnson & Johnson Stop the Bleeding?
Yahoo/CNBC
Monday, January 24, 2011 - 6:27pm
tags:
JNJ, recalls, earnings
Mylan to sell generic version of Pfizer's Protonix
Yahoo/AP
Monday, January 24, 2011 - 6:26pm
tags:
Pfizer, Protonix, Mylan, generics
INTERVIEW: AstraZeneca R&D Chief Seeks Alliances, In-Licensing
WSJ Online
Monday, January 24, 2011 - 12:49pm
tags:
AstraZeneca, R&D, in-licensing
GSK pushes two melanoma drugs into crowded Ph3 arena
Fierce Biotech
Monday, January 24, 2011 - 12:46pm
tags:
GSK, melanoma
Earnings Preview: Gilead Sciences
Yahoo/Zacks.com
Monday, January 24, 2011 - 12:45pm
tags:
Gilead Sciences, earnings
Earnings Preview: Abbott Labs reports 4Q earnings
Yahoo/AP
Monday, January 24, 2011 - 12:44pm
tags:
earnings, Abbott Laboratories
Earnings Preview: Johnson & Johnson
Seeking Alpha
Monday, January 24, 2011 - 12:43pm
tags:
JNJ, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.